ECHELON TITANIUM HIP SYSTEM

{0}------------------------------------------------ # 510(K) SUMMARY SMITH & NEPHEW ECHELON TITANIUM HIP SYSTEM MAY 1 5 2008 | SUBMITTER'S NAME: | Smith & Nephew, Inc., Orthopaedic Division | |------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | SUBMITTER'S ADDRESS: | 1450 Brooks Road, Memphis, TN 38116 | | SUBMITTER'S TELEPHONE NUMBER: | 901-399-6055 | | CONTACT PERSON: | Marlon D. Ridley | | DATE SUMMARY PREPARED: | January 16, 2008 | | TRADE OR PROPRIETARY DEVICE NAME: | Echelon Titanium Hip System | | COMMON OR USUAL NAME: | Prosthetic Hip Joint System-Porous Femoral Stem | | CLASSIFICATION NAME AND REFERENCE: | 21 CFR 888.3358 Hip Joint Metal/Polymer/Metal Semi-<br>Constrained Porous-Coated Uncemented Prosthesis - Class II<br>21 CFR 888.3350 Hip Joint Metal/Polymer Semi-Constrained<br>Cemented Prosthesis - Class II<br>21 CFR 888.3353 Hip Joint Metal/Ceramic/Polymer Semi-<br>Constrained - Class II<br>21 CFR 878.3300 Surgical Mesh - Class II | | PRODUCT CODE AND PANEL CODE: | Orthopaedics 87 / LPH / MBL / MEH / JDI / JDJ | ## PRC ### DEVICE INFORMATION: ### प्र INTENDED USE: The Echelon Titanium Hip System is indicated for individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips clamaged as a result of Irauma or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses of osteoarthritis, avascular necrosis, traumatic arthritis, slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant. Hip components are also indicated for inflammatory degenerative joint disease including rheumatoid arthritis, arthritis secondary to a variety of diseases and anomalies, and congenital dysplasia; old, remote osteomyelitis with an extended drainage-free period, in which case, the patient should be warned of an above normal danger of infection postoperatively, treatments of nonunion, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques; endoprosthesis, femoral osteolorny, or Girdlestone resection; fracture-dislocation of the hip; and correction of deformity. The Echelon Titanium Hip System is intended for single use only and implanted without bone cement. ### ന് DEVICE DESCRIPTION: The body of the Echelon Titanium Hip System femoral stems is similar in shape to the Anthology Hip Stem as previously cleared under premarket notification K052792. The material, porous coaling and surface finish of the Echelon Titanium Hip System fernoral stems are identical to the Anthology Hip Stern (K052792). The Echelon Titanium Hip System femoral stems are offered in primary and revision options featuring a 10/12 neck taper for use with the 10/12 Taper Femoral Heads. ### SUBSTANTIAL EQUIVALENCE INFORMATION: ﻝ The substantial equivalence of the Echelon Thanium Hip System is supported by II's Similarities in design features, overall indications, and material composition to table of legally marketed devices for total hip replacement. {1}------------------------------------------------ | COMPANY | PREDICATE DEVICE NAME | 510(κ) | CLEARANCE<br>DATE | |------------------------------------|--------------------------------------------------------------|---------|-------------------| | Smith & Nephew, Inc. | ANTHOLOGY® Hip Stems | K052792 | 10/07/2005 | | Wright Medical<br>Technology, Inc. | Profemur Renaissance Total Hip System | K051995 | 08/22/2005 | | Ortho Development<br>Corporation | Encompass Cemented Hip Stem and 10/12 Cobalt<br>Chrome Heads | K050637 | 09/23/2005 | | Smith & Nephew, Inc. | Global Taper Tapered Hip System | K963509 | 01/27/1997 | | Smith & Nephew, Inc. | Hip Joint Prosthesis (Richards Modular Hip System) | K924100 | 04/02/1993 | ### SUMMARY OF TECHNOLOGICAL COMPARISON: D. The intended use, design, and materials of the Echelon Titanium Hip System are similar to the legally marketed devices listed above. The Echelon Titanium Hip System components have the same technological characteristics as each of the legally marketed devices listed above as indicated for total hip replacement. {2}------------------------------------------------ DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes forming its body and tail. The eagle's head is facing left. Encircling the eagle is the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Smith & Nephew, Inc. % Mr. Jason Sells Project Manager, Regulatory Affairs 1450 Brooks Road Memphis, TN 38116 K072817 Re: Trade/Device Name: Echelon Titanium Hip System Regulation Number: 21 CFR 888.3358 Regulation Name: Hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis Regulatory Class: Class II Product Code: LPH, MBL, JDI, MEH, JDJ Dated: May 12, 2008 Received: May 13, 2008 Dear Mr. Sells: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. MAY 15 2008 If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {3}------------------------------------------------ Page 2 - Mr. Jason Sells This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at toll-free number (800) 638-2041 or (240) 276-3150 or the Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Mark M. Mullison Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ිංගිකරන පිළිබඳ විය Forsity & Presidents IFK 1 3 5 3 6 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 Marshap Res. Tra Raker 80 St A 1000 2019 12 22 23 23 www.analib naposuwoom - Smith&nephew # Indications for Use 一次不可是 # 510(k) Number (if known): Device Name: Echelon Titanium Hip System # Indications for Use: The Echelon Titanium Hip System is indicated for individuals undergoing primary and revision surgery where other treatments or devices have falled in rehabilitating hips damaged as a result of trauma or noninflammatory degenerative joint disease (NID)D) or any of its composite diagnoses of osteoarthrilis, avascular necrosis, traumatic anhrifis slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant. Hip components are also indicated for inflammatory degenerative joint disease including theumatoid arthritis, arthritis secondary to a variety of diseases and anomalies, and congenital dysplasia; old, remote osteomyelitis with an extended drainage-free period, which case, the patient should be warned of an above normal danger of infection postoperatively; treatments of nonunion, femoral neck fracture and trochariteric fractures of the proximal fernur with head involvement that are unmanageable using other techniques; endoprosthesis, femoral osfeotomy, or Girdlestone resection; fracture distocation of the hip; and correction of deformity. The Echelon Titanium Hip System is intended for single use only and implanted vittho bone cement Prescription Use IPart 21 CFR 801 Subpart Di Over-The-Counter Use AND/OR 21 CFR 807 Subpan CI IPLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED DRH, Office of Device Evaluation (ODE) Concurrance of Division Sign-Off Division of General, Restorative and Neurological Devices 510(k) Number K072817